Clinical Study
Venous Thromboembolism Following Colorectal Surgery for Suspected or Confirmed Malignancy
Table 1
Pharmacological VTE prophylaxis dose regimes.
| Pharmacological prophylaxis dose regime | % of patients | % of patients post discharge prophylaxis | 12 month VTE incidence (%) | Major bleeding complications (%) |
| LMWH 20 mg daily | 5.3 | 0.7 | 0 | 0 | LMWH 40 mg daily | 30 | 16 | 1.2 | 0.7 | LDUH 5000 IU twice daily | 30.7 | 4.7 | 1 | 1.3 | LDUH 5000 IU three times daily | 3.3 | 0.7 | 0 | 0 | LDUH followed by LMWH | 10.7 | 4.7 | 0.2 | 0.7 | None or inadequate LDUH | 20 | 4 | 0 | 0.7 |
|
|